Find Alzheimer’s Disease and Related Clinical Trials
Search for clinical trials and studies related to Alzheimer's, other dementias, mild cognitive impairment, and caregiving.
Results found: 28
Purpose: To identify reliable methods for tracking corticobasal degeneration and progressive supranuclear palsy.
Purpose: To assess the safety, tolerability, and behavior of the drug AL001 in healthy adult volunteers and people with frontotemporal dementia and the granulin mutation.
Purpose: To build a clinical research consortium to test new treatments for people with frontotemporal lobar degeneration.
Purpose: To learn how and why motor neuron degeneration begins and progresses in families affected by familial amytrophic lateral sclerosis (ALS).
Purpose: To test the safety, tolerability, and effects of the investigational drug BIIB092 in people with one of four different tauopathy syndromes.
Purpose: To evaluate the drug bosutinib as a treatment for people with dementia with Lewy bodies.
Purpose: To compare the effectiveness of two evidence-based models of dementia care.
Purpose: To characterize the clinical, neuropsychological, sleep, and neuroimaging findings among adults with Alzheimer's disease, Lewy body dementia, and Parkinson's disease.
Purpose: To learn more about the genetic causes of movement disorders and dementias.
Purpose: To test an iPad application for measuring neurological functioning.
Purpose: To assess eligibility for ongoing research, develop a registry for future trials, and gather biospecimens to carry out laboratory-based studies in adults with frontotemporal dementia, a motor neuron disorder, or related adult-onset neurodegenerative disorder.
Purpose: To evaluate the safety and tolerability of the study drug K0706 in people with dementia with Lewy bodies.
Purpose: To evaluate the safety and efficacy of the investigational drug LY3154207 in people with mild-to-moderate Parkinson's disease dementia.
Purpose: To further define the neurological and linguistic deterioration in primary progressive aphasia.
Purpose: To learn about thinking and behavior in families in which one or more relatives has a genetic mutation associated with frontotemporal dementia.
Purpose: To document the clinical features and biological markers of people with synucleinopathies (Parkinson's disease, dementia with Lewy bodies, or multiple system atrophy).
Purpose: To study adults with frontotemporal degeneration, multiple systems atrophy, and progressive supranuclear palsy to better understand the causes of these disorders.
Purpose: To evaluate the effects of nilotinib in adults with dementia with Lewy bodies.
Purpose: To enroll adults with idiopathic rapid eye movement sleep behavior disorder for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Purpose:To test a radioactive tracer for showing inflammation in the brain on positron emission tomography scans of people with progressive neurological disorders.
Purpose: To compare usual care to palliative care for adults with Parkinson's disease and related disorders.
Purpose: To investigate pupillary light response as a potential identifier of progressive supranuclear palsy (PSP).
Purpose: To evaluate two evidence-based speech language therapy treatments for adults with mild primary progressive aphasia.
Purpose: To investigate the effects of transcranial direct current stimulation during short-term memory therapy in people with primary progressive aphasia and related neurodegenerative conditions.
Purpose: To investigate the effects of transcranial direct current stimulation (tDCS) and language therapy on adults with PPA.
Purpose: To study the effects of transcranial direct current stimulation during language therapy in people with primary progressive aphasia.
Purpose: To identify and distinguish two different types of progressive apraxia of speech (PAOS) through clinical imaging and testing in adults with PAOS.
Purpose: To understand how behavioral variant frontotemporal dementia (bvFTD) affects people's day-to-day lives, how people think about themselves, and what challenges they face.